Well-being and symptoms in relation to insulin therapy in type 2 diabetes

Diabetes Care

Volumn 21, Issue 6, 1998, Pages 919-924

  De Sonnaville, Jeroen J J ^a,b   Snoek, Frank J ^a   Colly, Louisa P ^a   Devillé, Walter ^a   Wijkel, Dirk ^a   Heine, Robert J ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; GLUCOSE; HEMOGLOBIN A1C; ISOPHANE INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; DIABETES CONTROL; DIABETES MELLITUS; FEMALE; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; MOOD; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PATIENT SATISFACTION; SUBCUTANEOUS DRUG ADMINISTRATION; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADULT; AFFECT; AGED; BLOOD PRESSURE; CHOLESTEROL; CHOLESTEROL, HDL; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC DIET; EMOTIONS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; NETHERLANDS; PATIENT SATISFACTION; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; REGRESSION ANALYSIS; TRIGLYCERIDES;

EID: 3643065572     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.6.919     Document Type: Article

References (35)

1. Klein R: Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 18:258-268, 1995
2. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diab Res Clin Pract 28:103-117, 1995
3. Nathan DM, Singer DE, Godine JE, Harrington CH, Perlmuter LC: Retinopathy in older type II diabetes: association with glucose control. Diabetes 35:797-801, 1986
4. Reichard P, Nilsson B-Y, Rosenqvist U: The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304-309, 1993
5. Diabetes Control and Complication Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
6. Uusitupa MI, Niskanen LK, Siitonen O, Voutilainen E, Pyörälä K: Ten year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 36:1175-1184, 1993
7. Kuusisto J, Mykkänen L, Pyörä lä K, Laakso M: NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 43:960-967, 1994
8. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M: NIDDM and its metabolic control are important predictors of stroke in elderly subjects. Stroke 25:1157-1164, 1994
9. Malmberg K for the DIGAMI (Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group: Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ 314:1512-1515, 1997
10. Alberti KGMM, Cries FA, Jervell J, Krans HMJ, for the European NIDDM Policy Group: A desktop guide for the management of non-insulin-dependent diabetes mellitus (NIDDM): an update. Diabet Med 11:889-909, 1994
11. American Diabetes Association: Medical Management of Non-lnsulin-Dependent (Type II) Diabetes. 3rd ed, Alexandria, VA, American Diabetes Association, 1994
12. Groop LC, Pelkonen R: Treatment failures: a common problem in the management of patients with type II diabetes. Acta Endocnnol 105 (Suppl. 262): 131-135, 1984
13. United Kingdom Prospective Diabetes Study Group: United Kingdom Prospective Diabetes Study (UKPDS) 13: relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years. BMJ 310:83-88, 1995
14. Hunt LM, Valenzuela MA, Pugh JA: NIDDM patients' fears and hopes about insulin therapy: the basis of patient reluctance. Diabetes Care 20:292-298, 1997
15. Berger W: Insulin therapy in the elderly type 2 diabetic patient. Diabetes Res Clin Pract 4 (Suppl. 1):24-28, 1988
16. Peacock I, Tattersall RB: The difficult choice of treatment for poorly controlled maturity onset diabetes: tablets or insulin? Br Med J 288:1956-1959, 1984
17. Woffenbuttel BHR, Weber RFA, van Koetsveld PM, Weeks L, Verschoor L: A randomized crossover study of sulphonyl- urea and insulin treatment in patients with type 2 diabetes poorly controlled on dietary therapy. Diabet Med 6:520-525, 1989
18. Van der Does FEE, De Neeling JN, Snoek FJ, Kostense PJ, Grootenhuis PA, Bouter LM, Heine RJ: Symptoms and well-being in relation to glycemic control in type II diabetes. Diabetes Care 19:204-210, 1996
19. Assal JP, Mühlhauser I, Pernet A, Gfeller R, Jörgens V, Berger M: Patient education as the basis for diabetes care in clinical practice and research. Diabetologia 28:602-613, 1985
20. Yki-Yärvinen H, Kauppila M, Kujansuu E, Lahti J, Marjanen T, Niskanen L, Rajala S, Ryysy L, Salo S, Seppälä P, Tulokas T, Viikari J, Karjalainen J, Taskinen M-R: Comparison of insulin regimens in patients with noninsulin-dependent diabetes mellitus. N Engl J Med 327:1426-1433, 1992
21. Bradley C, Gamsu DS: Guidelines for encouraging psychological well-being: Report of a working group of the World Health Organization Regional Office for Europe and International Diabetes Federation European Region St Vincent Declaration Action Programme for Diabetes. Diabet Med 11:510-518, 1994
22. de Sonnaville JJJ, Bouma M, Colly LP, Devillé W, Wijkel D, Heine RJ: Sustained good glycemic control in NIDDM patients by implementation of structured care in general practice: 2 years follow-up study Dia- betoiogia 40:1334-1340, 1997
23. Grootenhuis PA, Snoek FJ, Heine RJ, Bouter LM: Development of a type 2 diabetes symptom checklist: a measure of symptom severity Diabet Med 11:253-261, 1994
24. Reddon JR, Marceau R, Holden RR: A confirmatory evaluation of the Profile of Mood States: convergent and discriminant item validity. J Psychopathol Behav Assessment 7:243-259, 1985
25. Wald FDM, Mellenbergh GJ: De verkorte versie van de Nederlandse vertaling van de Profile of Mood States (POMS). Ned Tijdschr Psychol 45:86-90, 1990
26. Barnett AH, Bowen Jones D, Burden AC, Janes JM, Sinclair A, Small M, Tindall H: Multicentre study to assess quality of life and glycaemic control of type 2 diabetic patients treated with insulin compared with oral hypoglycemic agents. Pract Diabet Int 13:179-183, 1996
27. Elgrably F, Costagliola D, Chwalow AJ, Varenne P, Slama G, Tchobroutsky G: Initiation of insulin treatment after 70 years of age: patient status 2 years later. Diabet Med 8:773-777, 1991
28. Wolffenbuttel BHR, Drossaen CH, Visser AP: Determinants of injecting insulin in elderly patients with type II diabetes mellitus, Patient Educ Couns 22:117-125, 1993
29. Henry RR, Gumbiner B, Ditzler T, Wallace P, Lyon R, Glauber HS: Intensive conventional insulin therapy for type II diabetes: metabolic effects during a 6-mo outpatient trial. Diabetes Care 16:21-31, 1993
30. Lindström T, Erikson P, Olsson AG, Arnqvist HJ: Long-term improvement of glycemic control by insulin treatment in NIDDM patients with secondary failure. Diabetes Care 17:719-721, 1994
31. Merbis MAE, Snoek FJ, Kanc K, Heine RJ: Hypoglycemia induces emotional disruption. Patient Educ Couns 29:117-122, 1996
32. Jacobson AM, the Diabetes Control and Complications Trial Research Group: The diabetes quality of life measure. In Handbook of Psychology and Diabetes. 1st ed. Bradley C, Ed. Chur, Switzerland, Harwood, 1994, p. 65-88
33. Abraira C, Colwell JA, Nuttall FQ, Sawin CT, Nagel NJ, Comstock JP, Emanuele NV, Levin SR, Henderson W, Lee HS: Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): results of the feasibility trial: Veterans Affairs Cooperative Study in Type II Diabetes. Diabetes Care 18:1113-1123, 1995
34. Töyry JP, Niskanen LK, Mantysaari MJ, Länsimies EA, Uusitupa IJ: Occurrence, predictors, and clinical significance of autonomic neuropathy in NIDDM: ten-year follow-up from the diagnosis. Diabetes 45:308-315, 1996
35. Taylor R: Insulin for the non-insulin dependent? Br Med J 296:1015, 1988